Login
← Go Back
Windlas Biotech
WINDLAS · Pharma > Pharmaceuticals & Drugs · Chairman: Vivek Dhariwal · MD: Hitesh Windlass · Listing date: Aug. 17, 2021 · Employees: 1028 · Gurugram · http://windlasbiotech.com
Stock Price vs Company Growth
1d
6.6%
1w
9.8%
1m
22.3%
3m
12.1%
6m
5.1%
1y
18.6%
all
18.5%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 866 6.6%
699
967
Company Overview
Sales
868 Cr
Growth: 17.9%
Profit after Tax
66.7 Cr
Growth: -0.9%
Small Cap
1,828 Cr
P/E: 27.5x
Industry P/E: 28.0x
Fundamentals
Sales (Cr) ₹ 868
Growth 17.9%
EBITDA 12.1%
P/S 2.1x
Dividend 0.6%
P/E 27.5x
Book Value ₹ 264
PEG Ratio 1.5x
ROE 12.6%
P/B 3.3x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world. Awards, accreditations and recognitions2018: The company was awarded the TV100 Industrial Excellence Award in the field of medicine.
Belongs to (4 Indices)
Investors (3)
jainam.b...
ajay.kum...
ravi036
Followers (2)
kotekar
varsha96